Alliance Global Partners initiated coverage on XORTX Therapeutics with a new price target
$XRTX
Biotechnology: Pharmaceutical Preparations
Health Care
Alliance Global Partners initiated coverage of XORTX Therapeutics with a rating of Buy and set a new price target of $11.00